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Background In countries with high economic growth index, life expectancy and working age are increasing, which will result in growing numbers of people in the workforce with chronic diseases,
including cancer, in the near future. Epidemiologic data show that approximately half of the new diagnoses and more than 1/3 of cancer survivors (CSs) are in their working age [1]. Patients treated for
cancer experience pain, fatigue, cognitive dysfunction, and mood disorders that may adversely affect social outcomes, such as reintegration into the workplace after cancer treatment. Return to work
(RTW) of cancer survivors is a major goal, as it facilitates patient’s ability to deal with the disease, recover personal identity and social role, and improve general health [2-4]. Systematic reviews show
a 64% employment rate for CSs, with high variability in different contexts (range 24% -94%) [5,6]. However, the generalizability of the results is frequently limited, since the reintegration to work may
significantly differ depending on the context analyzed. Therefore, the principal aim of this study is to review the recent literature on the RTW rate of CSs in Europe. Secondly, we want to identify those
factors potentially associated with reintegration to work. Lastly, we present data regarding the duration of sick leave (SL) of European CSs. This systematic review has been accepted for publication
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Figure 1. Flow chart showing inclusion/exclusion of individual articles for systematic review
Results
Return to work in cancer survivors
The twelve studies included in this review, conducted in United Kingdom, France, The Nether-
lands, Denmark, Norway, Finland and Iceland, represent the Northwestern Europe. RTW rates
of CSs in their working age was reported by four studies [7,8,9,10] and ranged from 39% [9] to 77% [7].
RTW rates in CSs employed at the time of diagnosis was reported by ten studies [8,10-18], ranging
from the 60% [11] to the 92% [17], the latter registered in a sample with good prognosis.
Prognostic factors for RTW in CSs
Factors analyzed were largely heterogeneous between studies. Protective factors were positively
associated to higher rates of RTW, or faster RTW, or higher number of hours worked by CSs
per time unit. Risk factors were associated to lower rate of RTW, or slower RTW, or change in
employment status. The associations of personal factors and cancer-related factors with RTW
were identified in the majority of the selected studies, whereas the influence of work-related fac-
tors on reintegration at work was explored by five studies only [8,13-15,17]. Support provided by the
healthcare team in coping with RTW issues was investigated in two studies and was reported as
protective factor by both [7,14].





• living with partner/children
• employed at diagnosis
• female gender
• low income
• <30 and >50 years old
Work-related
• support from supervisor
• support from colleagues
• decision latitude
• discrimination at work
• low social support at work
• self-employment
• permanent job
• physically demanding work
• intellectually demanding work
Cancer-related • good prognosis
• metastatic disease
• upper aerodigestive cancer
• lung cancer
• further diagnostic phase
• chemotherapy, active treatment
• adverse effects
Rehabilitative • discuss employment issue with HCPs (Health care professionals)
Figure 2. Protective factors and risk factors associated with return to work (RTW)
Sick Leave
The duration of SL was analyzed by six studies [7,8,11-13,17], with highly heterogeneous reporting of
data. The average duration of SL was 6-12 months in two large samples [11,13]. However, SL lasted
less than 6 months for a consistent proportion of the individuals under investigation [7,13,17]. Long-
lasting SL (≥ 2 years) was associated with physically demanding work [8] and with blood, lung,
and gastrointestinal cancers for 30% of individuals affected [12] and, to a lesser extent (nearly 20%),
with upper aerodigestive tract and breast cancers [8,12]. Finally, the time to full or partial RTW
was significantly longer in the year 2008 than in 2002 (p<0.01) [11].
Conclusions There is urgent need for data from Mediterranean and Central Europe, to understand whether RTW is problematic in CSs and whether socio-rehabilitative interventions are required
to mitigate the potential negative impact of cancer on individuals and society. The multidisciplinary rehabilitation interventions should be tailored to the individual, feasible in the context of interest,
and effective in addressing unemployment in CSs.
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